E4H worked with leading pharmaceutical company, UCB Pharma Ltd, to deliver a branded webinar in Scotland to launch its new treatment for severe osteoporosis in postmenopausal women at high risk of fracture.
The inaugural Bone Health Forum meeting took place in early February 2021 and featured an evening of insightful presentations.
Delivered by an expert faculty, the meeting explored the important role of its bone-forming agent within the current treatment landscape for postmenopausal women with severe osteoporosis at high risk of fracture.
E4H supported the client at every stage to deliver the inaugural event.
Alongside E4H’s quality, webinar delivery programme, the project management and digital team worked closely with the client to develop a process to ensure that all attendees were verified as a UK healthcare professional. This process has now been automated and will be used at UCB Pharma Ltd’s next event with E4H, the Bone Health Forum in June.
Omni-Channel Marketing and Communications